Abstract:ID 93978 Poster Board 520 Altered dopamine signaling in the central nervous system (CNS) has been the subject of many studies, as it has become a fundamental feature of numerous CNS diseases and disorders, including Parkinson's disease (PD) and substance use disorder (SUD). The dopamine transporter (DAT) is the primary regulator of dopamine (DA) signaling in the central nervous system (CNS) and in the periphery. This member of the re-uptake-1 monoamine transporters (MATs) clears extracellular dopamine by transporting it into the cell for storage. Recent studies have shown that peripheral immune cells such as monocytes and macrophages express DAT and the norepinephrine transporter (NET), and that DAT regulates innate immune response. Alterations of DAT in the CNS impacts the expression of this protein in peripheral immune cells affecting immune regulation. Development of methodologies and tools that will facilitate our understanding of the mechanism underlying these observations can facilitate strategies to study DAT-associated disease and disorders in the periphery. Fluorescently labelled ligands (FLL) have proven useful as tools to study protein expression, localization, and distribution and downstream processes in distinct live cell systems, opening a venue to study endogenously expressed proteins. In this work, we set out to develop a high affinity and selective FLL for the detection of DAT in peripheral blood mononuclear cells (PBMCs) by flow cytometry. For our synthetic design, we identified two atypical DAT inhibitors, JJC8-087 and JJC8-089, as parent ligands. These compounds bind with high affinity to DAT and selectivity over SERT and NET. Fluorescent labelling of the parent ligand was based on previously reported structure-activity relationship studies. Binding affinities of all final compounds for rDAT, rSERT and rNET were obtained via radioligand binding assay in Sprague-Dawley rat brain tissue and hDAT-HEK293 cell membranes. PBMCs were isolated from whole blood via density media centrifugation and samples treated with either the FLL or a control antibody were analyzed via flow cytometry on a 5-laser Cytek Aurora Spectral Cytometer. Probes based on JJC8-087 demonstrated the highest DAT affinity and were selective with respect to SERT and NET. The lead DiSulfoCy5 FLL, GC04-38 (rDAT K i = 159 nM) was ~26-fold rDAT selective over rSERT ( K i = 4.2 mM) and >63-fold selective over rNET ( K i = >10 mM), in addition, a similar binding affinity for hDAT was obtained ( K i = 191 nM). GC04-38 was used to label DAT in both mouse and human peripheral blood mononuclear cells (PBMCs) and analyzed via flow cytometry revealing comparable results with a control DAT antibody, reducing the time of sample preparation from 165 minutes (antibody control) to 30 min (FLL). We validated the selective detection of DAT with PBMCs isolated from a DAT knockout mouse demonstrating high specificity of this FLL. Overall, our results suggest a robust use for this novel FLL probe to increase our understanding of CNS-peripheral DAT regulation mechanisms underlying health and disease. This research is funded by the National Institutes of Health (NIH) – National Institute on Drug Abuse (NIDA) - Intramural Research Program.

A novel fluorescently labelled ligand for the detection of DAT in immune cells by flow cytometry

Fluorescently Labelled Ligand Allow Detection of DAT in Human and Mouse Peripheral Blood Monocytes by Flow Cytometry

Modulating an in Situ Fluorogenic Reaction for the Label-Free Ratiometric Detection of Biothiols.

Membrane mobility and microdomain association of the dopamine transporter studied with fluorescence correlation spectroscopy and fluorescence recovery after photobleaching

Design, synthesis, and characterization of a novel, 4-[2-(diphenylmethoxy)ethyl]-1-benzyl piperidine-based, dopamine transporter photoaffinity label

Synthesis and biological evaluation of 18 F-labelled deuterated tropane derivatives as dopamine transporter probes

Multimodal Detection of Dopamine by Sniffer Cells Expressing Genetically Encoded Fluorescent Sensors

Turn-on fluorescent probe for dopamine detection in solutions and live cells based on in situ formation of aminosilane-functionalized carbon dots

A novel red fluorescence dopamine biosensor selectively detects dopamine in the presence of norepinephrine in vitro

Characterization of the neuronal dopamine transporter DAT in human blood platelets

Functional characterization of the biogenic amine transporters on human macrophages

An Efficient and Label-Free LC-MS/MS Method for Assessing Drug's Activity at Dopamine and Serotonin Transporters Using Transporter-Transfected HEK293T Cells.

Synthesis and initial evaluation of radioiodine-labelled deuterated tropane derivatives targeting dopamine transporter

Optical Fibers Functionalized with Single-Walled Carbon Nanotubes for Flexible Fluorescent Catecholamine Detection

Structural Analysis, Molecular Modelling and Preliminary Competition Binding Studies of AM-DAN as a NMDA Receptor PCP-Site Fluorescent Ligand

TUNEL-n-DIFL Method for Detection and Estimation of Apoptosis Specifically in Neurons and Glial Cells in Mixed Culture and Animal Models of Central Nervous System Diseases and Injuries

Tunable Fluorescent Artificial Receptor Biosensor Based on Programmable Lanthanide Metal‐Organic Framework for Highly Selective Neurotransmitter Detection

A fluorescent nanosensor paint detects dopamine release at axonal varicosities with high spatiotemporal resolution

Recent Advances In Reaction-Based Fluorescent Probes For The Detection Of Central Nervous System-Related Pathologies In Vivo

3-aminophenylboronic Acid Modified Carbon Nitride Quantum Dots as Fluorescent Probe for Selective Detection of Dopamine and Cell Imaging

Human dopamine transporter: the first implementation of a combined in silico/in vitro approach revealing the substrate and inhibitor specificities